200 ans de la cristallerie du Val Saint Lambert
2026 marquera les 200 ans de la cristallerie du Val Saint Lambert. L’Université de Liège a décidé de réaliser une exposition portant sur le verre dans la société actuelle.
As a public university open to the world and is anchored in the scientific, cultural and economic development of its region, the University of Liège relies on its three pillars: teaching, research and civic engagement.
ULiège trains responsible citizens who are provided with cutting-edge knowledge and critical thinking, are able to share knowledge and can push forward an increasingly complex world.
ULiège develops and promotes excellence in research, multidisciplinary and direct engagement with its instruction.
Global exposure is a top priority at the University of Liège. The institution offers a wide range of international mobility opportunities to students, researchers and staff, enabling them to enhance their cross-disciplinary skills and language knowledge.
ULiège: an experience of daily living. Located in 3 cities and 4 campuses, the university is a key player in terms of the environment and mobility.
Arnaud Lombard, F.R.S.-FNRS researcher in the GIGA neurosciences (Faculty of Medicine) is the winner of the first ICAB (Arsène Burny Cancer Institute) prize. This prize is awarded for his research on brain tumours and more particularly on glioblastoma.
A
rnaud Lombard graduated in medicine (2013) and neurosurgery in (2019) and defended his thesis in biomedical sciences in February 2019. He is currently a FNRS post-doctoral researcher in the laboratory of Prof. Bernard Rogister at GIGA-Neuroscience and Chief of Clinic in Neurosurgery at the University Hospital of Liège. His research focuses on establishing new targets and new therapies to fight glioblastoma, a malignant but very common primary brain tumour with a very poor prognosis (average survival of 18 months).
“My research project consists of carrying out mass spectrometry in the laboratory on tumour cells from patients, in order to identify new membrane markers specific to these cells. Once identified, these new membrane markers can be targeted through the production of tiny specific antibodies or "nanobodies". Finally, these nanobodies can be coupled to an oncolytic virus or a radioisotope, for example, in such a way as to specifically induce the death of cells that express the marker. »
Arnaud Lombard receives the first prize of the ICAB (Institut de Cancérologie Arsène Burny) created by the Fondation Léon Fréderic in collaboration with the ICAB of the CHU of Liege. This prize will enable him to finance part of his laboratory project on brain tumours and a training stay at the Pitié-Salpêtrière Hospital in Paris, also in the field of brain tumours.
The ICAB prize is a prize of the Fondation Léon Fréderic in collaboration with the Institut de Cancérologie Arsène Burny of the CHU of Liège. Awarded for the first time in 2022 on the occasion of the inauguration of the institute, the ICAB prize is intended to support a clinical, translational or fundamental research project in the field of cancer. The prize is worth 10,000 euros and is awarded annually. Half of the prize is intended for the winner and the other half is intended to support the operating costs of the project.
2026 marquera les 200 ans de la cristallerie du Val Saint Lambert. L’Université de Liège a décidé de réaliser une exposition portant sur le verre dans la société actuelle.
A new study at ULiège and a call to established entrepreneurs and young entrepreneurs in student incubators
Prof. David Lyden (Weill Cornell Medical College) inaugurated at ULiège the series of lectures and meetings in Belgium on The pre-metastatic nice concept.